Matthew D Galbraith

19PUBLICATIONS
60CO-AUTHORS
Developmental genetics (incl. sex determination)Immunogenetics (incl. genetic immunology)AutoimmunityMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 11, 2026
Systematic multi-omic deconvolution of the clinical heterogeneity of Down syndrome.

|Sep 24, 2025
An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21.

Neetha Paul Eduthan, Micah G Donovan, Paula Araya

|Feb 10, 2025
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome.

Kira A Cozzolino, Lynn Sanford, Samuel Hunter

|Dec 31, 2024
JAK inhibition decreases the autoimmune burden in Down syndrome.

Angela L Rachubinski, Elizabeth Wallace, Emily Gurnee

|Dec 13, 2024
Integrated analysis of immunometabolic interactions in Down syndrome.

Lucas A Gillenwater, Matthew D Galbraith, Angela L Rachubinski

|Jul 01, 2024
JAK inhibition decreases the autoimmune burden in Down syndrome.

Angela L Rachubinski, Elizabeth Wallace, Emily Gurnee

Pageof 4

Frequent Collaborators

15 joint publications

Joaquín M Espinosa

10 joint publications

Kelly D Sullivan

5 joint publications

Angela L Rachubinski

3 joint publications

James C Costello